Abstract
The description of the pathogenic events which underly the production of any particular disease is a relatively easy exercise when the etiology of the disease and its symptoms are well established. However, such is not the case with hypertension, for high blood pressure is not itself a disease but merely one of a family of common symptomatic manifestations which develop in response to various pathologies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Report of the Hypertension Task Force. National Institutes of Health; Heart, Blood and Lung Institute. Volume 1: General Summary and Recommendations, p. 1628. NIH Publication No. 79, 1979.
Guyton AC, Coleman TG, Cowley AW Jr, Manning RD Jr, Norman RA Jr, Ferguson JD: A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ Res 35: 159, 1974.
Cowley A: Personal communication.
McCubbin JW, Green JH, Page IH: Baroreceptor function in chronic renal hypertension. Circ Res 4: 205, 1956.
Kezdi P, Wennemark J: Baroreceptor and sympathetic activity in experimental renal hypertension. Circulation 17: 785, 1958.
Krieger EM: Time course of baroreceptor resetting in acute hypertension. Am J Physiol 218: 486, 1970.
Henry JP, Gauer OH, Reeves JL: Evidence of the atrial location of receptors influencing urine flow. Circ Res 4: 85, 1956.
Mancia G, Lorenz RR, Shepherd JT: reflex control of circulation by heart and lungs. In: International Review of Physiology, Cardiovascular, Physiology - II, Vol. 9, p. 111. Guyton AC, Cowley AW, eds. Baltimore: University Park Press, 1976.
Thoren PN: Characteristic of left ventrivular receptors with non-medullated vagal afferents in cats. Circ Res 40: 415, 1977.
Gauer OH, Henry JP: Neurohormonal control of plasma volume. In: Cardiovascular Physiology - II, Vol. 9, pp. 145–190. Guyton AC, Cowley AV, eds. Baltimore: University Park Press, 1976.
Epstein M, Pins DS, Arlington R, Denunzio AG, Engstrom R: Comparison of water immersion and saline infusion as a means of inducing volume expansion in man. J Appl Physiol 39: 66, 1975.
Behne HJ, Gauer OH, Kirsch K, Eckert P: Effects of sustained intrathoracic vascular distention on body fluid distribution and renal excretion in man. Pfluegers Arch 313: 123, 1969.
Gilmore JP, Zucker IM: Failure of left atrial distention to alter renal function in the non-human primate. Circ Res 42: 267, 1978.
Mancia G, Romero JC, Shepherd JT: Continuous inhibition of renin release in dags by vagally innervated receptors in the cardiopulmonary region. Circ Res 36: 529, 1975.
Mancia G, Romero JC, Strong CG: Neural influences on canine renal prostaglandin secretion. Acta Physiol Lat Am 24: 555, 1974.
Thames MD: Reflex suppression of renin release by ventricular receptors with vagal afferents. Am J Physiol 233:HI81, 1978.
Kiowski W, Julius S: Renin response to stimulation of cardiopulmonary mechanoreceptors in man. J Clin Invest 62: 656, 1978.
Thames MD, Zubair-ul-Hassan, Brackett NC, Lower RR, Kontos HA: Plasma renin responses to hemorrhage after cardiac autotransplantation. Am J Physiol 221: 1115, 1971.
Roddie C, Shepherd JT, Whelan RF: Reflex changes in vasoconstrictor tone in human skeletal muscle in response to stimulation of receptors in a low-pressure area of the intra-thoracic vascular bed. J Physiol 139: 369, 1957.
Epstein M, Pins DS, Miller M: Suppression of ADH during water immersion in normal man. J Appl Physiol 38: 1038, 1975.
Share L: The role of cardiovascular receptors in the control of ADH release. Cardiology 61 (Suppl 1): 51, 1976.
Gupta PD, Henry JP, Sinclair R, von Baumgarten R: Responses of atrial and aortic baroreceptors to nonhypotensive hemorrhage and to transfusion. Am J Physiol 211: 1429, 1966.
Davis JO, Freeman RH: Mechanisms regulating renin release. Physiol Rev 56: 1, 1976.
Guyton AC, Cowley AW Jr, Coleman TG, Liard JF, McCaa RE, Manning RD Jr, Norman RA Jr, Young DB: Pretubular versus tubular mechanisms of renal hypertension. In: Mechanisms of Hypertension, pp. 15–29. Sambhi MP, ed. Amsterdam: Excerpta Medica, 1973.
Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313, 1977.
Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232, 1971.
Romero JC, Dunlap CL, Strong CG: The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest 58: 282, 1976.
Weber PC, Larson C, Anggard E, Hamberg M, Corey EJ, Nicolau KC, Samuelsson B: Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endoperoxides. Circ Res 39: 868, 1976.
Weber PC, Larson C, Scherer B: Prostaglandin E2-9-keto-reductase as a mediator of salt intake-related prostaglandin-renin interaction. Nature 266: 65, 1977.
Beierwaltes WH, Schryver S, Olson PS, Romero JC: Interaction of the prostaglandin and renin-angiotensin systems in isolated rat glomeruli. Am J Physiol (in press).
Romero JC, Strong CG: Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system. Mayo Clin Proc 52: 462, 1977.
Romero JC, Beierwaltes WH: Renal prostaglandins in hypertension. Mineral Water Metab (in press).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Romero, J.C., Beierwaltes, W.H., Houck, P.C. (1982). The Pathophysiology of Hypertension: Contributions of Experimental Pathophysiology. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-7476-0_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7478-4
Online ISBN: 978-94-009-7476-0
eBook Packages: Springer Book Archive